144 related articles for article (PubMed ID: 10064561)
1. Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans.
Dupont I; Berthou F; Bodenez P; Bardou L; Guirriec C; Stephan N; Dreano Y; Lucas D
Drug Metab Dispos; 1999 Mar; 27(3):322-6. PubMed ID: 10064561
[TBL] [Abstract][Full Text] [Related]
2. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.
Yun CH; Okerholm RA; Guengerich FP
Drug Metab Dispos; 1993; 21(3):403-9. PubMed ID: 8100494
[TBL] [Abstract][Full Text] [Related]
4. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
5. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
Yamazaki H; Shaw PM; Guengerich FP; Shimada T
Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
Chang TK; Weber GF; Crespi CL; Waxman DJ
Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617
[TBL] [Abstract][Full Text] [Related]
7. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
Kim PM; Wells PG
Mol Pharmacol; 1996 Jan; 49(1):172-81. PubMed ID: 8569704
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
Labroo RB; Paine MF; Thummel KE; Kharasch ED
Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
[TBL] [Abstract][Full Text] [Related]
10. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism.
Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV
Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317
[TBL] [Abstract][Full Text] [Related]
11. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes.
Marre F; Fabre G; Lacarelle B; Bourrie M; Catalin J; Berger Y; Rahmani R; Cano JP
Drug Metab Dispos; 1992; 20(2):316-21. PubMed ID: 1352227
[TBL] [Abstract][Full Text] [Related]
14. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
Gebhardt AC; Lucas D; Ménez JF; Seitz HK
Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
[TBL] [Abstract][Full Text] [Related]
16. Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Drug Metab Dispos; 1998 May; 26(5):483-9. PubMed ID: 9571230
[TBL] [Abstract][Full Text] [Related]
17. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver.
Lemoine A; Gautier JC; Azoulay D; Kiffel L; Belloc C; Guengerich FP; Maurel P; Beaune P; Leroux JP
Mol Pharmacol; 1993 May; 43(5):827-32. PubMed ID: 8502233
[TBL] [Abstract][Full Text] [Related]
18. Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.
Thummel KE; Kharasch ED; Podoll T; Kunze K
Drug Metab Dispos; 1993; 21(2):350-7. PubMed ID: 8097708
[TBL] [Abstract][Full Text] [Related]
19. Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.
Fleming CM; Branch RA; Wilkinson GR; Guengerich FP
Mol Pharmacol; 1992 May; 41(5):975-80. PubMed ID: 1588928
[TBL] [Abstract][Full Text] [Related]
20. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
